Skip to main content
Watch Insiders

Corporate insider profile

Beth Hecht Insider Trades

Latest reported as See Remarks of Xeris Biopharma Holdings, Inc. (XERS).

Purchase filings
0
Reported companies
1
Net open-market value
-$770,426.47
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

XERSLatest reported

Xeris Biopharma Holdings, Inc.

See Remarks

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale16,666$9.41$156,792
Sep 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale16,666$8.49$141,434
Aug 3, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale16,666$8.01$133,553
Jul 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale16,666$8.03$133,860
Jun 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale16,667$6.06$100,982
May 1, 2026Xeris Biopharma Holdings, Inc. (XERS)See RemarksSale16,667$6.23$103,805